CADENCE BANK NA - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
CADENCE BANK NA ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$445,0000.0%10,2220.0%0.14%
+16.1%
Q1 2022$445,000
-1.3%
10,2220.0%0.12%
+0.8%
Q4 2021$451,000
+15.3%
10,2220.0%0.12%
+6.0%
Q3 2021$391,000
-3.2%
10,222
+0.8%
0.12%
-4.1%
Q2 2021$404,000
+11.6%
10,1440.0%0.12%
+6.1%
Q1 2021$362,000
-2.2%
10,144
+1.0%
0.11%
-13.0%
Q4 2020$370,000
-55.1%
10,044
-54.1%
0.13%
-59.1%
Q3 2020$824,000
-1.8%
21,899
+6.5%
0.32%
-9.9%
Q2 2020$839,000
+12.2%
20,558
+4.1%
0.36%
-6.8%
Q1 2020$748,000
+27.6%
19,749
+58.3%
0.38%
+76.4%
Q4 2019$586,000
+39.5%
12,474
+26.8%
0.22%
+31.7%
Q3 2019$420,000
+8.8%
9,835
+2.0%
0.16%
+9.3%
Q2 2019$386,000
-3.7%
9,641
+0.3%
0.15%
-4.5%
Q1 2019$401,000
+7.5%
9,615
-1.5%
0.16%
-6.5%
Q4 2018$373,000
+58.1%
9,761
+78.7%
0.17%
+55.6%
Q2 2017$236,000
-12.3%
5,461
-14.7%
0.11%
-12.9%
Q1 2017$269,000
-20.6%
6,403
-27.1%
0.12%
-22.0%
Q4 2016$339,000
-10.8%
8,781
-0.3%
0.16%
-7.6%
Q3 2016$380,000
-1.0%
8,807
-0.5%
0.17%
-9.0%
Q2 2016$384,000
+28.9%
8,855
+20.4%
0.19%
+22.7%
Q1 2016$298,000
+41.9%
7,352
+34.9%
0.15%
+27.3%
Q3 2015$210,000
-0.9%
5,450
+6.9%
0.12%
-11.7%
Q2 2015$212,0005,0990.14%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2020
NameSharesValueWeighting ↓
OSTERWEIS CAPITAL MANAGEMENT INC 1,948,915$79,029,0004.59%
Chubb Ltd 400,000$16,220,0004.42%
Pegasus Partners Ltd. 172,275$6,986,0003.79%
Keystone Financial Planning, Inc. 117,762$4,775,0003.42%
P.R. Herzig & Co. Inc. 36,950$1,498,0003.28%
Sterneck Capital Management, LLC 112,535$4,563,0003.21%
Hamlin Capital Management, LLC 1,454,031$58,961,0002.98%
Healthcare Value Capital, LLC 50,000$2,028,0002.98%
Jolley Asset Management, LLC 80,639$3,270,0002.98%
JFB Holdings Corp 2,415,570$97,951,0002.91%
View complete list of GLAXOSMITHKLINE PLC shareholders